Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients
Status:
Unknown status
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the safety,tolerability,pharmacokinetics and
pharmacodynamics of Pegfilgrastim in patients with chemotherapy-induced neutropenia.
Phase:
Phase 1
Details
Lead Sponsor:
Hangzhou Jiuyuan Gene Engineering Co. Ltd.,
Collaborator:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences